Corporate Governance, Board Management & M&A ExitsPlaybook3 min readUpdated September 2026

Bridge Note or SAFE: Which Fits Your Next Raise

When you need cash between priced rounds, a convertible note structured as a bridge loan and a SAFE both let investors put money in now and convert it into equity later, usually at a discount to your next round's price. They are not the same instrument, though, and the difference matters most if your next round takes longer to happen than anyone expected.

Here is how the two actually compare on the terms that matter.

Vendors Covered in this Article

Disclosure: We may earn a commission if you buy through some links on this page. It doesn't change what we recommend.

Does a SAFE have a maturity date like a bridge note?

A promissory note, including a convertible bridge note, has a maturity date, a point at which the loan technically becomes due and repayable if it has not already converted. A SAFE has no maturity date at all; it simply waits to convert whenever a qualifying event happens, with no deadline forcing a decision. This is the single biggest structural difference, since a note's approaching maturity date can force an uncomfortable conversation with investors if your next priced round has not happened yet.

Interest: another feature unique to notes

A note typically accrues interest, which adds to the principal balance and converts into additional shares at conversion, while a SAFE, true to its name, is not a debt instrument and carries no interest at all. For a founder, no interest is a modest advantage of a SAFE, since it means slightly less dilution at conversion compared to an equivalent note that accrued interest over the same period.

Discount rates and valuation caps: where the two instruments look similar

Both instruments commonly include a discount rate, giving the bridge investor a lower effective price per share than new investors in the priced round, and a valuation cap, setting a ceiling on the valuation used to calculate the conversion price regardless of where the actual round prices. These terms function similarly in both structures, so the real negotiation here is usually about the specific discount percentage and cap amount, not which instrument you are using.

What happens if your next round takes longer than planned?

This is where the difference actually bites. A SAFE simply keeps waiting for a qualifying event with no deadline pressure. A note approaching its maturity date without a triggering event forces a real decision: extend the maturity date with investor consent, repay the loan in cash you likely do not have, or negotiate some other resolution. If you expect your timeline to slip, that difference alone can be a strong reason to prefer a SAFE over a note.

Deciding which instrument fits your situation

If you are highly confident your next priced round will happen well within a typical maturity window, the practical difference between the two narrows considerably and other factors, like investor preference or what is standard in your specific market, can drive the decision. If your timeline is uncertain, the absence of a maturity date is a real, structural advantage of a SAFE worth weighing seriously before you default to whichever instrument your last bridge round happened to use.

Weigh these factors when choosing between the two:

  • How confident you are that a priced round will close well within a typical maturity window, since high confidence narrows the practical gap between the two instruments.
  • Whether your timeline could slip, because a SAFE waits with no deadline while a note's maturity date can force an extension or repayment conversation.
  • Whether interest matters to you, since a note's accrued interest converts into extra shares and a SAFE carries none.
  • Which discount rate and valuation cap you are willing to offer, since these terms work much the same way in either instrument.
  • What investors in your market expect, because investor preference can drive the decision when the structural differences are small.

What actually happens at conversion, once your priced round arrives

At conversion, whichever instrument you used calculates its final price using the lower of the discount applied to the new round's price or the price implied by the valuation cap, whichever is more favorable to the investor. A note's accrued interest gets added to the converting principal first, so it also converts into shares, meaning noteholders end up with slightly more shares than a SAFE holder who put in the same original amount over the same period. This is a real, quantifiable dilution difference worth explaining clearly to your cap table if you have used both instruments across different bridge rounds.

Mixing instruments across the same bridge round

Some companies raise a single bridge round using a mix of notes and SAFEs, often because different investors have different preferences, which is generally fine as long as every investor's terms, discount, cap, and instrument type, are clearly documented and consistently applied within whatever each investor negotiated. What creates problems is inconsistency that was not intentional, such as one investor getting a materially better discount with no clear reason, which tends to surface as a fairness question later when investors compare notes, sometimes literally.

Executive Capability Standard

What Good Looks Like

Good practice means understanding exactly which instrument, note or SAFE, you are issuing, tracking any maturity dates closely if you use notes, and negotiating the discount and cap terms deliberately rather than defaulting to whatever template is handy.

Building The Capability (5-Stage Skill Ladder)

1. Learn:Read the specific terms of your existing bridge instruments, if any, and confirm whether they carry a maturity date and interest rate or not.
2. Do Manually:Build a simple calendar of any maturity dates across your outstanding notes so you are not surprised by an approaching deadline.
3. Delegate:Have a fractional CFO track your outstanding bridge instruments and flag any approaching maturity date well before it arrives.
4. Automate:Use a bill pay and reminder tool like BILL to flag upcoming maturity or interest dates on outstanding notes so nothing is missed.
5. Buy:Bring in an attorney to draft or review the specific instrument, note or SAFE, before you accept bridge financing, since the terms are easy to get wrong without experience.

How to Get Started

Disclosure: We may earn a commission if you buy through some links on this page. It doesn't change what we recommend.

Frequently Asked Questions

Do I have to repay a bridge note if my company never raises another round?

Technically yes, since it is a debt instrument with a maturity date, though in practice many early-stage companies without the cash to repay negotiate an extension or another resolution with the noteholders rather than defaulting. A SAFE has no repayment obligation at all, since it is not structured as debt.

Is a SAFE always better for a founder than a convertible note?

Not universally. A SAFE avoids interest and a maturity date, which is generally favorable to founders, but investors sometimes prefer the greater legal protections and defined timeline that come with a note's debt structure, so the instrument that gets used often depends on investor preference as much as founder preference.

Can a bridge note and a SAFE have the same discount rate and valuation cap?

Yes, these terms are largely independent of the underlying instrument type, so a note and a SAFE can carry very similar discount and cap terms. The instrument choice mainly affects maturity, interest, and the legal characterization of the investment, not the pricing mechanics.

About the numbers

This guide doesn't quote a sourced benchmark. Figures in it are estimates or general guidance, so check them against your own numbers.

Related Guides